Your browser doesn't support javascript.
loading
MicroRNA regulation of endothelial TREX1 reprograms the tumour microenvironment.
Wilson, RaeAnna; Espinosa-Diez, Cristina; Kanner, Nathan; Chatterjee, Namita; Ruhl, Rebecca; Hipfinger, Christina; Advani, Sunil J; Li, Jie; Khan, Omar F; Franovic, Aleksandra; Weis, Sara M; Kumar, Sushil; Coussens, Lisa M; Anderson, Daniel G; Chen, Clark C; Cheresh, David A; Anand, Sudarshan.
Afiliação
  • Wilson R; Department of Cell, Developmental and Cancer Biology, Department of Radiation Medicine, Oregon Health and Science University, Portland, Oregon 97229, USA.
  • Espinosa-Diez C; Department of Cell, Developmental and Cancer Biology, Department of Radiation Medicine, Oregon Health and Science University, Portland, Oregon 97229, USA.
  • Kanner N; Department of Cell, Developmental and Cancer Biology, Department of Radiation Medicine, Oregon Health and Science University, Portland, Oregon 97229, USA.
  • Chatterjee N; Department of Cell, Developmental and Cancer Biology, Department of Radiation Medicine, Oregon Health and Science University, Portland, Oregon 97229, USA.
  • Ruhl R; Department of Cell, Developmental and Cancer Biology, Department of Radiation Medicine, Oregon Health and Science University, Portland, Oregon 97229, USA.
  • Hipfinger C; Department of Cell, Developmental and Cancer Biology, Department of Radiation Medicine, Oregon Health and Science University, Portland, Oregon 97229, USA.
  • Advani SJ; Department of Radiation Medicine and Applied Sciences, University of California, San Diego, California 92093, USA.
  • Li J; Department of Neurosurgery, University of California, San Diego, California 92093, USA.
  • Khan OF; Department of Chemical Engineering, Institute for Medical Engineering and Science, David H Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA.
  • Franovic A; Department of Pathology at the UC San Diego Moores Cancer Center and Sanford Consortium for Regenerative Medicine, University of California, San Diego, La Jolla, California 92037, USA.
  • Weis SM; Department of Pathology at the UC San Diego Moores Cancer Center and Sanford Consortium for Regenerative Medicine, University of California, San Diego, La Jolla, California 92037, USA.
  • Kumar S; Department of Cell, Developmental and Cancer Biology, Department of Radiation Medicine, Oregon Health and Science University, Portland, Oregon 97229, USA.
  • Coussens LM; Department of Cell, Developmental and Cancer Biology, Department of Radiation Medicine, Oregon Health and Science University, Portland, Oregon 97229, USA.
  • Anderson DG; Department of Chemical Engineering, Institute for Medical Engineering and Science, David H Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA.
  • Chen CC; Department of Neurosurgery, University of California, San Diego, California 92093, USA.
  • Cheresh DA; Department of Pathology at the UC San Diego Moores Cancer Center and Sanford Consortium for Regenerative Medicine, University of California, San Diego, La Jolla, California 92037, USA.
  • Anand S; Department of Cell, Developmental and Cancer Biology, Department of Radiation Medicine, Oregon Health and Science University, Portland, Oregon 97229, USA.
Nat Commun ; 7: 13597, 2016 11 25.
Article em En | MEDLINE | ID: mdl-27886180
ABSTRACT
Rather than targeting tumour cells directly, elements of the tumour microenvironment can be modulated to sensitize tumours to the effects of therapy. Here we report a unique mechanism by which ectopic microRNA-103 can manipulate tumour-associated endothelial cells to enhance tumour cell death. Using gain-and-loss of function approaches, we show that miR-103 exacerbates DNA damage and inhibits angiogenesis in vitro and in vivo. Local, systemic or vascular-targeted delivery of miR-103 in tumour-bearing mice decreased angiogenesis and tumour growth. Mechanistically, miR-103 regulation of its target gene TREX1 in endothelial cells governs the secretion of pro-inflammatory cytokines into the tumour microenvironment. Our data suggest that this inflammatory milieu may potentiate tumour cell death by supporting immune activation and inducing tumour expression of Fas and TRAIL receptors. Our findings reveal miR-mediated crosstalk between vasculature and tumour cells that can be exploited to improve the efficacy of chemotherapy and radiation.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fosfoproteínas / MicroRNAs / Exodesoxirribonucleases / Microambiente Tumoral / Neoplasias / Neovascularização Patológica Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fosfoproteínas / MicroRNAs / Exodesoxirribonucleases / Microambiente Tumoral / Neoplasias / Neovascularização Patológica Idioma: En Ano de publicação: 2016 Tipo de documento: Article